The Enterprise Value as of June 2026 (TTM) for Regen BioPharma, Inc. (RGBPP) is 970.96K

According to Regen BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 970.96K. This represents a change of -43.76% compared to the average of 1.73M of the last 4 quarters.

Regen BioPharma, Inc. (RGBPP) Historical Enterprise Value (quarterly & annually)

How has RGBPP Enterprise Value performed in the past?

The mean historical Enterprise Value of Regen BioPharma, Inc. over the last ten years is 9.50M. The current 970.96K Enterprise Value has changed 922.19% with respect to the historical average. Over the past ten years (40 quarters), RGBPP's Enterprise Value was at its highest in in the September 2021 quarter at 67.18M. The Enterprise Value was at its lowest in in the March 2026 quarter at 1.08M.

Regen BioPharma, Inc. (RGBPP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Regen BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Regen BioPharma, Inc. (RGBPP) Average Enterprise Value

How has RGBPP Enterprise Value performed in the past?

The current Enterprise Value of Regen BioPharma, Inc. (RGBPP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Regen BioPharma, Inc. (RGBPP) Enterprise Value vs. Peers

How is RGBPP’s Enterprise Value compared to its peers?

Regen BioPharma, Inc.’s Enterprise Value is less than Restart Life Sciences Corp. (2.50M), greater than ReNeuron Group plc (-5684648.11), less than Appili Therapeutics Inc. (14.17M), less than Ayala Pharmaceuticals, Inc. (29.14M), greater than Algernon Pharmaceuticals Inc. (-52507.00), less than Zelira Therapeutics Limited (8.08M), less than ProtoKinetix, Incorporated (2.04M), less than Universal Ibogaine Inc. (4.01M), greater than HAVN Life Sciences Inc. (487.77K), less than RepliCel Life Sciences Inc. (1.92M),

Build a custom stock screener for Regen BioPharma, Inc. (RGBPP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regen BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Regen BioPharma, Inc. (RGBPP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Regen BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.